We are live on ! Find out more
AC

Argentiere Capital Portfolio holdings

AUM $15.4M
1-Year Est. Return 8.82%
This Fund
S&P 500
This Quarter Est. Return
-0.04%
1 Year Est. Return
-8.82%
3 Year Est. Return
+1.98%
5 Year Est. Return
+9.17%
10 Year Est. Return
AUM
$129M
AUM Growth
-$42.8M
Cap. Flow
+$95.9M
Cap. Flow %
74.64%
Top 10 Hldgs %
76.75%
Holding
90
New
27
Increased
2
Reduced
11
Closed
36

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$20.5M
2
DHR icon
Danaher
DHR
+$15.6M
3
APD icon
Air Products & Chemicals
APD
+$13.7M
4
AAPL icon
Apple
AAPL
+$12.2M
5
PFE icon
Pfizer
PFE
+$9.15M

Sector Composition

Rank Sector Weight
1 Financials 13.5%
2 Technology 8.49%
3 Energy 6.31%
4 Materials 3.74%
5 Consumer Staples 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
26
PUT
Morgan Stanley
MS
$331B
$698K 0.54%
350,000
-150,000
-30% -$3.92M
XLF icon
27
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$663K 0.52%
33,035
GILD icon
28
PUT
Gilead Sciences
GILD
$162B
$649K 0.5%
150,000
-50,000
-25% -$4.44M
YPF icon
29
YPF
YPF
$206B
$576K 0.45%
30,000
PRKS icon
30
United Parks & Resorts
PRKS
$2.1B
$573K 0.45%
40,000
GE icon
31
CALL
GE Aerospace
GE
$374B
$529K 0.41%
83,465
-208,662
-71% -$30.4M
DD icon
32
PUT
DuPont de Nemours
DD
$18.5B
$474K 0.37%
78,976
INTC icon
33
CALL
Intel
INTC
$455B
$464K 0.36%
437,400
-162,600
-27% -$5.09M
WMT icon
34
PUT
Walmart Inc
WMT
$885B
$453K 0.35%
+1,050,000
New +$24.3M
BABA icon
35
CALL
Alibaba
BABA
$293B
$448K 0.35%
+100,000
New +$7.83M
COST icon
36
PUT
Costco
COST
$422B
$445K 0.35%
+130,000
New +$19.7M
BMY icon
37
PUT
Bristol-Myers Squibb
BMY
$133B
$435K 0.34%
150,000
-25,000
-14% -$1.77M
AAPL icon
38
PUT
Apple
AAPL
$4.54T
$417K 0.32%
+600,000
New +$14.9M
RDEN
39
DELISTED
ELIZABETH ARDEN INC
RDEN
$416K 0.32%
30,202
XOM icon
40
CALL
ExxonMobil
XOM
$644B
$373K 0.29%
+100,000
New +$8.84M
BABA icon
41
PUT
Alibaba
BABA
$293B
$358K 0.28%
+100,000
New +$7.83M
EEM icon
42
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$351K 0.27%
+1,000,000
New +$33.6M
PFE icon
43
CALL
Pfizer
PFE
$143B
$340K 0.26%
+210,800
New +$6.73M
MS icon
44
CALL
Morgan Stanley
MS
$331B
$333K 0.26%
350,000
-150,000
-30% -$3.92M
BHC icon
45
Bausch Health
BHC
$2.58B
$326K 0.25%
+16,200
New +$459K
LMT icon
46
CALL
Lockheed Martin
LMT
$134B
$310K 0.24%
+50,000
New +$11.8M
GILD icon
47
CALL
Gilead Sciences
GILD
$162B
$290K 0.23%
200,000
BMY icon
48
CALL
Bristol-Myers Squibb
BMY
$133B
$281K 0.22%
150,000
-25,000
-14% -$1.77M
BID
49
DELISTED
Sotheby's
BID
$274K 0.21%
10,000
LMT icon
50
PUT
Lockheed Martin
LMT
$134B
$270K 0.21%
+50,000
New +$11.8M

Similar funds

Argentiere Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Argentiere Capital held 90 positions worth $129M, down 25% from $171M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Argentiere Capital deployed $95.9M of net new capital in Q2 2016, opening 27 new positions and adding to 2 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 1,139,700 shares worth $39M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 1.4% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Apple, an estimated $12.2M trimmed.

  • Argentiere Capital's largest Q2 2016 buy was iShares China Large-Cap ETF: 1,139,700 shares worth $39M.
  • Argentiere Capital's biggest Q2 2016 reduction was Apple, cutting an estimated $12.2M.
  • Argentiere Capital fully exited Allergan plc in Q2 2016, selling an estimated $20.5M.
  • Argentiere Capital's ten largest holdings make up 77% of its $129M portfolio in Q2 2016.
  • Argentiere Capital opened 27 new positions and closed 36 in Q2 2016.
  • Argentiere Capital's portfolio value fell 25% quarter-over-quarter to $129M.

Based on Argentiere Capital's 13F filing for Q2 2016, filed 9 Aug 2016.